by Dr Joseph Mercola at Mercola
- Based on the scientific evidence, the narrative that unvaccinated people are viral factories for more dangerous variants is false
- Just as antibiotics breed resistance in bacteria, vaccines put evolutionary pressure on viruses to speed up mutations and create more virulent and dangerous variants
- Viruses mutate all the time, and if you have a vaccine that doesn’t block infection completely, then the virus will mutate to evade the immune response within that person. That is one of the distinct features of the COVID shots — they’re not designed to block infection. They allow infection to occur and at best lessen the symptoms of that infection
- In an unvaccinated person, the virus does not encounter the same evolutionary pressure to mutate into something stronger. So, if SARS-CoV-2 does end up mutating into more lethal strains, then mass vaccination is the most likely driver
- So far, SARS-CoV-2 variants are at most 0.3% different from the original Wuhan virus. Such minor variation means the virus will not present itself as a new virus. If you’ve recovered from COVID-19, your immune system will still recognize it
Will COVID shots drive the mutation of SARS-CoV-2, creating ever more variants? Or are the mutations primarily occurring in unvaccinated people? In the video report above, The Last American Vagabond host dives into the scientific research to find out.
As noted by The Vagabond, unvaccinated Americans are actually in the majority, still, despite what you’re hearing on the news. Those saying “no” to participating in a medical gene modification experiment are not a small fringe group.
We are the majority, at just over half (51%) of the United States population over the age of 18, as of July 12, 2021. (More specifically, 56% have received one dose, and 49% are fully vaccinated, which for Moderna and Pfizer means having received two doses.1)
Based on the scientific evidence, the narrative that unvaccinated people are viral factories for more dangerous variants is simply false. Worse, it’s the complete opposite of the truth and hides the fact that mass vaccination may be putting us all in a far direr situation than necessary.
Vaccines Drive Viruses to Mutate
As explained in “Vaccines Are Pushing Pathogens to Evolve,” published in Quanta Magazine,2 “Just as antibiotics breed resistance in bacteria, vaccines can incite changes that enable diseases to escape their control.”
The article details the history of the anti-Marek’s disease vaccine for chickens, first introduced in 1970. Today, we’re on the third version of this vaccine, as within a decade, it stops working. The reason? The virus has mutated to evade the vaccine. The virus is also becoming increasingly deadly and more difficult to treat.
A 2015 paper3 in PLOS Biology tested the theory that vaccines are driving the mutation of the herpesvirus causing Marek’s disease in chickens. To do that, they vaccinated 100 chickens and kept 100 unvaccinated. All of the birds were then infected with varying strains of the virus. Some strains were more virulent and dangerous than others.
Over the course of the birds’ lives, the unvaccinated ones shed more of the least virulent strains into the environment, while the vaccinated ones shed more of the most virulent strains. As noted in the Quanta Magazine article:4
“The findings suggest that the Marek’s vaccine encourages more dangerous viruses to proliferate. This increased virulence might then give the viruses the means to overcome birds’ vaccine-primed immune responses and sicken vaccinated flocks.”
Vaccinated People Can Serve as Breeding Ground for Mutations
As noted by Reilly, before 2021, it was quite clear that vaccines push viruses to mutate into more dangerous strains. The only question was, to what extent? Now all of a sudden, we’re to believe conventional science has been wrong all along.
Here’s another example: NPR as recently as February 9, 2021, reported that “vaccines can contribute to virus mutations.” NPR science correspondent Richard Harris noted:5
“You may have heard that bacteria can develop resistance to antibiotics and, in a worst-case scenario, render the drugs useless. Something similar can also happen with vaccines, though, with less serious consequences.
This worry has arisen mostly in the debate over whether to delay a second vaccine shot so more people can get the first shot quickly. Paul Bieniasz, a Howard Hughes investigator at the Rockefeller University, says that gap would leave people with only partial immunity for longer than necessary.”
According to Bieniasz, partially vaccinated individuals “might serve as sort of a breeding ground for the virus to acquire new mutations.” This is the exact claim now being attributed to unvaccinated people by those who don’t understand natural selection.
It’s important to realize that viruses mutate all the time, and if you have a vaccine that doesn’t block infection completely, then the virus will mutate to evade the immune response within that person. That is one of the distinct features of the COVID shots — they’re not designed to block infection. They allow infection to occur and at best lessen the symptoms of that infection. As noted by Harris:6
“This evolutionary pressure is present for any vaccine that doesn’t completely block infection … Many vaccines, apparently, including the COVID vaccines, do not completely prevent a virus from multiplying inside someone even though these vaccines do prevent serious illness.”
In short, like bacteria mutate and get stronger to survive the assault of antibacterial agents, viruses can mutate in vaccinated individuals who contract the virus, and in those, it will mutate to evade the immune system. In an unvaccinated person, on the other hand, the virus does not encounter the same evolutionary pressure to mutate into something stronger. So, if SARS-CoV-2 does end up mutating into more lethal strains, then mass vaccination is the most likely driver.
COVID Variants Are More Similar Than You Think
Now, the fearmongering over variants is just that: fearmongering. So far, while some SARS-CoV-2 variants appear to spread more easily, they are also less dangerous. The Delta variant, for example, is associated with more conventional flu-like symptoms like runny nose and sore throat than the hallmark COVID-19 symptoms involving shortness of breath and loss of smell.7
In an interview for the documentary “Planet Lockdown,”8 Michael Yeadon, Ph.D., a life science researcher and former vice-president and chief scientist at Pfizer, pointed out the fraud being perpetrated with regard to variants. He actually refers to them as “simians,” because they’re near-identical to the original. And, as such, they pose no greater threat than the original.
“It’s quite normal for RNA viruses like SARS-CoV-2, when it replicates, to make typographical errors,” Yeadon explains. “It’s got a very good error detection, error correction system so it doesn’t make too many typos, but it does make some, and those are called ‘variants.’
It’s really important to know that if you find the variant that’s most different from the sequence identified in Wuhan, that variance … is only 0.3% different from the original sequence.
I’ll say it another way. If you find the most different variance, it’s 99.7% identical to the original one, and I can assure you … that amount of difference is absolutely NOT possibly able to represent itself to you as a different virus.”
Your immune system is a multifaceted system that allows your body to mount defenses against all sorts of threats. Parasites, fungi, bacteria and viruses are the main threat categories. Each of these invades and threatens you in completely different ways, and your immune system has ways of dealing with all of them, using a variety of mechanisms.
Whether you’re going to be susceptible to variants has very little to do with whether or not you have antibodies against SARS-CoV-2, because antibodies are not your primary defense against viruses, T cells are. What this means then, is that getting booster shots for different variants is not going to help, because these shots do not strengthen your T cell immunity.
The importance of T cells has been known for a long time, and their role in COVID-19 was confirmed early on in the pandemic. Scientists wanted to find out if patients who recovered from SARS-CoV-1, responsible for the SARS outbreak some 17 years ago, might have immunity against SARS-CoV-2. As it turns out, they did.
They still had memory T cells against SARS-CoV-1, and those cells also recognized SARS-CoV-2, despite being only 80% similar. Now, if a 20% difference was not enough to circumvent the immune system of these patients, why should you be concerned with a variant that is at most 0.3% different from the original SARS-CoV-2?
“When your government scientists tell you that a variant that’s 0.3% different from SARS-CoV-2 could masquerade as a new virus and be a threat to your health, you should know, and I’m telling you, they are lying,” Yeadon says.
“If they’re lying, and they are, why is the pharmaceutical industry making top-up [booster] vaccines? … There’s absolutely no possible justification for their manufacture.”
Mutations Are Good for Vaccine Business
Of course, by pushing fear of variants, vaccine makers ensure a steady supply of people willing to participate as guinea pigs in their for-profit business scheme. Pfizer plans to ask for EUA authorization for a third COVID booster shot in August 2021, Bloomberg reports.9
According to Pfizer’s head of research, Dr. Mikael Dolsten, initial data suggest a third dose of the current Pfizer shot can raise neutralizing antibody levels by anywhere from fivefold to 10-fold.10 The company is also working on variant-specific formulations.
Dolsten points to data from Israel, where Pfizer’s mRNA injection was used exclusively, which shows a recent uptick in breakthrough cases. This suggests protection starts to wane around the six-months mark. For now, the FDA is not recommending boosters,11 but that can change at any moment, and most likely will.
Pfizer recently announced it intends to raise the price on its COVID shot once the pandemic wanes,12 and during a recent investor conference, Pfizer’s chief financial officer Frank D’Amelio said there’s “significant opportunity” for profits once the market shifts to annual boosters.13
In an April 2021 article, The Defender reported expected profits from current COVID shots and boosters in coming years:14
- Pfizer expects a minimum revenue of $15 billion to $30 billion in 2021 alone
- Moderna expects sales of $18.4 billion in 2021; Barclays analyst Gena Wang forecasts the company’s 2022 revenue to be somewhere around $12.2 billion and $11.4 billion in 2023
- Johnson & Johnson expects sales of $10 billion in 2021